Foghorn Therapeutics Inc. (FHTX): Total Assets
$198.10M
As of 2025-12-31
$203.39M
As of 2026-06-30
-21.2%
3-year compound annual growth
-5.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $198.10M | -30.2% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $283.98M | -0.7% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $285.92M | -29.4% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $404.88M | -22.1% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $519.77M | +103.4% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $255.59M | n/m | 2022-08-09, Balance as of period end |
| 2019-12-31 | $22.34M | n/a | 2021-03-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $198.10M | -30.2% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $246.44M | +142.7% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $127.04M | -38.7% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $42.21M | +31.1% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $47.13M | -12.9% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $8.97M | +26.9% |
| Celularity Inc (CELU) | 2025-12-31 | $107.33M | -19.1% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $30.08M | -1.6% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $19.27M | -59.5% |
Compare FHTX, VSTM, ZOMDF, CUE side by side · Screen every company in Pharmaceutical Preparations ↗